S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
NASDAQ:ESTA

Establishment Labs (ESTA) Stock Price, News & Analysis

$44.11
-1.57 (-3.44%)
(As of 03/1/2024 ET)
Today's Range
$43.06
$46.95
50-Day Range
$24.74
$45.68
52-Week Range
$16.96
$79.88
Volume
727,005 shs
Average Volume
403,293 shs
Market Capitalization
$1.14 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$64.00

Establishment Labs MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
45.1% Upside
$64.00 Price Target
Short Interest
Bearish
18.25% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.94mentions of Establishment Labs in the last 14 days
Based on 13 Articles This Week
Insider Trading
Acquiring Shares
$54,080 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.77) to ($0.62) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.54 out of 5 stars

Medical Sector

533rd out of 950 stocks

Surgical Appliances & Supplies Industry

12th out of 18 stocks


ESTA stock logo

About Establishment Labs Stock (NASDAQ:ESTA)

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

ESTA Stock Price History

ESTA Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Establishment Labs Hldgs: Q4 Earnings Insights
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
15 Countries with Most Breast Implants in the World
ESTA Establishment Labs Holdings Inc.
See More Headlines
Receive ESTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/03/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:ESTA
Fax
N/A
Employees
958
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$64.00
High Stock Price Target
$105.00
Low Stock Price Target
$47.00
Potential Upside/Downside
+45.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-75,210,000.00
Pretax Margin
-38.49%

Debt

Sales & Book Value

Annual Sales
$165.15 million
Book Value
($0.34) per share

Miscellaneous

Free Float
22,546,000
Market Cap
$1.14 billion
Optionable
Optionable
Beta
1.23
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Juan Jose Chacon QuirosMr. Juan Jose Chacon Quiros (Age 52)
    Founder, CEO & Executive Director
    Comp: $913.37k
  • Mr. Rajbir Singh Denhoy (Age 54)
    Chief Financial Officer
    Comp: $570.29k
  • Mr. S. Ross Mansbach (Age 57)
    General Counsel & Chief Compliance Officer
    Comp: $379.53k
  • Mr. Roberto de Mezerville (Age 43)
    Chief Technology Officer
  • Mr. Salvador Santos Dada (Age 42)
    Head of Special Projects
    Comp: $468.62k
  • Ms. Rosalyn Cole d'Incelli
    SVP of Global Clinical, Medical & US Regulatory Affairs
  • Ms. Elizabeth Panzica Newman
    VP & Head of U.S Business Unit
  • Mr. Ivan Bilic
    Senior Vice President of Commercial Operations - OUS
  • Ms. Neeta Toprani
    Corporate Secretary














ESTA Stock Analysis - Frequently Asked Questions

Should I buy or sell Establishment Labs stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ESTA shares.
View ESTA analyst ratings
or view top-rated stocks.

What is Establishment Labs' stock price target for 2024?

6 Wall Street analysts have issued twelve-month target prices for Establishment Labs' stock. Their ESTA share price targets range from $47.00 to $105.00. On average, they anticipate the company's stock price to reach $64.00 in the next twelve months. This suggests a possible upside of 45.1% from the stock's current price.
View analysts price targets for ESTA
or view top-rated stocks among Wall Street analysts.

How have ESTA shares performed in 2024?

Establishment Labs' stock was trading at $25.89 at the start of the year. Since then, ESTA shares have increased by 70.4% and is now trading at $44.11.
View the best growth stocks for 2024 here
.

When is Establishment Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our ESTA earnings forecast
.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) issued its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.79) EPS for the quarter, topping analysts' consensus estimates of ($0.95) by $0.16. The firm earned $31.60 million during the quarter, compared to the consensus estimate of $31.44 million. Establishment Labs had a negative trailing twelve-month return on equity of 339.52% and a negative net margin of 47.53%. The firm's revenue for the quarter was down 27.9% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.55) earnings per share.

What ETFs hold Establishment Labs' stock?

ETFs with the largest weight of Establishment Labs (NASDAQ:ESTA) stock in their portfolio include Simplify Health Care ETF (PINK).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

What guidance has Establishment Labs issued on next quarter's earnings?

Establishment Labs updated its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $174.0 million-$184.0 million, compared to the consensus revenue estimate of $173.7 million.

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

When did Establishment Labs IPO?

(ESTA) raised $50 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

Who are Establishment Labs' major shareholders?

Establishment Labs' stock is owned by many different retail and institutional investors. Top institutional shareholders include Brown Advisory Inc. (9.41%), Findell Capital Management LLC (2.20%), Fourth Sail Capital LP (2.17%), Kornitzer Capital Management Inc. KS (1.51%), Iron Triangle Partners LP (1.28%) and Nuveen Asset Management LLC (1.10%). Insiders that own company stock include Dennis E Condon, Dennis E Condon, Edward J Schutter, Jw Asset Management, Llc, Leslie Gillin, Lisa Gersh, Mezerville Roberto De, Nicholas Sheridan Lewin, Raj Denhoy and Renee Gaeta.
View institutional ownership trends
.

How do I buy shares of Establishment Labs?

Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ESTA) was last updated on 3/3/2024 by MarketBeat.com Staff